Transcriptomics

Dataset Information

0

MiaPaCa-2 xenografts SHP2i + ERKi


ABSTRACT: KRAS mutant pancreatic tumors have poor prognosis and few therapeutic options. Here, Frank et al. show that the combination of RMC4550 (SHP2 inhibitor) and LY3214996 (ERK inhibitor)  effectively impairs tumor growth and induces tumor regression in multiplein vivo models of PDAC .

ORGANISM(S): Homo sapiens

PROVIDER: GSE213697 | GEO | 2022/11/15

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2022-11-15 | GSE213698 | GEO
2020-10-01 | GSE149815 | GEO
2021-07-29 | GSE180964 | GEO
2017-05-02 | GSE98399 | GEO
2024-05-29 | PXD043585 | Pride
2024-05-29 | PXD048529 | Pride
2024-05-29 | PXD048531 | Pride
2024-05-29 | PXD048532 | Pride
2024-05-29 | PXD048534 | Pride
2023-01-23 | GSE217810 | GEO